BVF INC/IL - ESSA PHARMA INC ownership

ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 35 filers reported holding ESSA PHARMA INC in Q3 2023. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of ESSA PHARMA INC
ValueSharesWeighting
Q3 2023$27,033,264
+14.4%
8,748,6290.0%0.73%
+10.8%
Q2 2023$23,621,298
-9.1%
8,748,6290.0%0.66%
-30.7%
Q1 2023$25,983,428
+17.9%
8,748,6290.0%0.95%
+2.2%
Q4 2022$22,046,545
+38.5%
8,748,6290.0%0.93%
+41.3%
Q3 2022$15,923,000
+36.7%
8,748,629
+136.5%
0.66%
+16.9%
Q2 2022$11,651,000
-49.0%
3,698,629
+0.1%
0.56%
-38.4%
Q1 2022$22,839,000
-43.6%
3,695,629
+29.6%
0.91%
-37.8%
Q4 2021$40,491,000
+77.5%
2,851,4610.0%1.47%
+65.2%
Q3 2021$22,812,000
-67.4%
2,851,461
+16.3%
0.89%
-66.1%
Q2 2021$70,041,000
-17.1%
2,451,561
-15.7%
2.62%
-17.1%
Q1 2021$84,487,000
+91.1%
2,908,326
-21.5%
3.17%
+82.2%
Q4 2020$44,204,000
+113.1%
3,705,289
+23.3%
1.74%
+53.9%
Q3 2020$20,739,000
+68.5%
3,005,589
+51.4%
1.13%
+48.9%
Q2 2020$12,306,000
+27.1%
1,984,889
-18.0%
0.76%
-15.9%
Q1 2020$9,682,000
-33.3%
2,420,565
-8.3%
0.90%
-18.1%
Q4 2019$14,523,000
+63.2%
2,640,5650.0%1.10%
+17.8%
Q3 2019$8,899,000
+188.5%
2,640,565
+98.6%
0.94%
+177.4%
Q2 2019$3,085,000
+54.9%
1,329,700
+129.1%
0.34%
+51.1%
Q1 2019$1,991,000
+63.3%
580,3680.0%0.22%
+40.3%
Q4 2018$1,219,000
-29.6%
580,368
+0.6%
0.16%
+4.6%
Q3 2018$1,731,000
-17.2%
576,771
+4.3%
0.15%
-25.5%
Q2 2018$2,090,000552,7910.20%
Other shareholders
ESSA PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 4,145,117$12,310,9971.28%
BVF INC/IL 8,748,629$25,983,4280.95%
Ally Bridge Group (NY) LLC 236,583$702,6520.92%
PFM Health Sciences, LP 4,161,461$12,359,5390.55%
Bellevue Group AG 7,898,583$23,458,7920.34%
Rhenman & Partners Asset Management AB 356,500$1,051,6750.12%
Orbimed Advisors 1,198,337$3,559,0610.07%
Privium Fund Management (UK) Ltd 20,032$61,4980.05%
Rock Springs Capital Management LP 524,944$1,559,0840.04%
Hunting Hill Global Capital, LLC 10,000$29,7000.02%
View complete list of ESSA PHARMA INC shareholders